ArticleCureus2025
Hemophagocytic Lymphohistiocytosis in a Patient With Hodgkin's Lymphoma Mimicking Sinusoidal Obstructive Syndrome: A Diagnostic Challenge.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening hyperinflammatory syndrome triggered by malignancy, infection, or autoimmune disease. We present a case of a 19-year-old male with Hodgkin's lymphoma who developed high-grade fevers, hepatomegaly, and severe liver injury shortly after receiving chemotherapy. He was initially diagnosed with sinusoidal obstructive syndrome (SOS) and treated with defibrotide. Despite therapy, his condition deteriorated, prompting transfer to our institution for evaluation of acute liver failure and suspected drug-induced liver injury (DILI). Further diagnostic evaluation revealed markedly elevated serum ferritin and soluble interleukin-2 receptor (sCD25), and bone marrow biopsy demonstrated prominent hemophagocytosis. These findings confirmed the diagnosis of HLH, likely secondary to underlying Hodgkin's lymphoma and possible Epstein-Barr virus (EBV) reactivation. The patient was initiated on high-dose corticosteroids with rapid clinical and biochemical improvement. This case underscores the diagnostic complexity of HLH, particularly in lymphoma patients undergoing chemotherapy, where overlapping syndromes can delay accurate diagnosis, and highlights the critical importance of early recognition to initiate timely, life-saving immunosuppressive therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.